ArticleCureus2026
A Simpler Draw: Rethinking Colorectal Cancer Screening for Adults With Intellectual and Developmental Disabilities.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adults with intellectual and developmental disabilities (IDD) face substantial barriers to colorectal cancer screening, including communication difficulties, caregiver burden, and difficulty completing stool collection or bowel preparation. These barriers likely contribute to lower screening completion and higher cancer-related mortality in this population. Blood-based colorectal cancer screening, which can be completed during a routine blood draw without stool collection or bowel preparation, may reduce several of these logistical barriers. However, most adults with IDD are insured through Medicaid, and current coverage for the leading blood-based test excludes Medicaid beneficiaries in nearly all states, undermining the accessibility argument for this population specifically. We argue that blood-based screening deserves consideration as part of an individualized, equity-focused approach to colorectal cancer prevention in adults with IDD, provided it is offered alongside, not instead of, higher-sensitivity options, and we call for expanded Medicaid coverage and continued improvement in test performance to close the gap between accessibility and effectiveness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.